JPWO2022158591A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022158591A5 JPWO2022158591A5 JP2022576771A JP2022576771A JPWO2022158591A5 JP WO2022158591 A5 JPWO2022158591 A5 JP WO2022158591A5 JP 2022576771 A JP2022576771 A JP 2022576771A JP 2022576771 A JP2022576771 A JP 2022576771A JP WO2022158591 A5 JPWO2022158591 A5 JP WO2022158591A5
- Authority
- JP
- Japan
- Prior art keywords
- aminolevulinic acid
- hypertrophic cardiomyopathy
- agent
- esters
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims 6
- 229960002749 aminolevulinic acid Drugs 0.000 claims 6
- 150000002148 esters Chemical class 0.000 claims 6
- 206010020871 hypertrophic cardiomyopathy Diseases 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- 150000002506 iron compounds Chemical class 0.000 claims 3
- 230000003205 diastolic effect Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000010117 myocardial relaxation Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 230000002861 ventricular Effects 0.000 claims 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021009754 | 2021-01-25 | ||
| PCT/JP2022/002413 WO2022158591A1 (ja) | 2021-01-25 | 2022-01-24 | 肥大型心筋症治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022158591A1 JPWO2022158591A1 (enExample) | 2022-07-28 |
| JPWO2022158591A5 true JPWO2022158591A5 (enExample) | 2025-01-22 |
Family
ID=82548732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022576771A Pending JPWO2022158591A1 (enExample) | 2021-01-25 | 2022-01-24 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240082189A1 (enExample) |
| EP (1) | EP4309651A4 (enExample) |
| JP (1) | JPWO2022158591A1 (enExample) |
| CN (1) | CN116829138A (enExample) |
| WO (1) | WO2022158591A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06012636A (es) | 2004-04-28 | 2007-03-21 | Yoshiyasu Ito | Regenerador de cabello. |
| JP5098051B2 (ja) * | 2007-04-05 | 2012-12-12 | Ｓｂｉファーマ株式会社 | ミトコンドリア障害脳疾患治療剤及び診断剤 |
| JP5611548B2 (ja) * | 2009-07-08 | 2014-10-22 | Ｓｂｉファーマ株式会社 | ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤 |
| JP7430916B2 (ja) * | 2018-09-20 | 2024-02-14 | 国立大学法人北海道大学 | 心不全の病態の評価のための方法、バイオマーカー、候補化合物の評価方法、医薬用組成物及び心不全の治療剤 |
| US20240173283A1 (en) * | 2021-03-23 | 2024-05-30 | Kyushu University, National University Corporation | Prophylactic agent or therapeutic agent for side effects of anthracycline anticancer agent |
-
2022
- 2022-01-24 WO PCT/JP2022/002413 patent/WO2022158591A1/ja not_active Ceased
- 2022-01-24 EP EP22742710.1A patent/EP4309651A4/en active Pending
- 2022-01-24 JP JP2022576771A patent/JPWO2022158591A1/ja active Pending
- 2022-01-24 CN CN202280011367.6A patent/CN116829138A/zh active Pending
- 2022-01-24 US US18/262,840 patent/US20240082189A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021550328A1 (en) | Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject | |
| US20110244045A1 (en) | Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation | |
| ES2545959T3 (es) | Un medicamento consistente en un derivado de carboestirilo y donepezilo para el tratamiento de la enfermedad de Alzheimer | |
| JP2008543854A5 (enExample) | ||
| JP2015527402A5 (enExample) | ||
| ATE475415T1 (de) | Neue salze des wirkstoffs rasagilin | |
| JP2008501753A5 (enExample) | ||
| JPS60188323A (ja) | 心筋虚血治療用医薬組成物 | |
| CA2606140A1 (en) | External preparation for skin | |
| MY201355A (en) | "compositions comprising amino acids for use in the prevention and treatment of liver diseases" | |
| WO2018232298A1 (en) | Anti-fungals compounds targeting the synthesis of fungal sphingolipids | |
| AR119974A1 (es) | Composición radiofarmacéutica concentrada, estable | |
| AR065316A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologiamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
| JP2018524351A5 (enExample) | ||
| HRP20161675T1 (hr) | Dabigatran-amidoksim-esteri karboksilnih kiselina kao prolijekovi i njihova uporaba kao lijekova | |
| RU2008110644A (ru) | Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств | |
| JPWO2022158591A5 (enExample) | ||
| CA2051369C (en) | Thyroid hormone cardiac treatment | |
| JP2007501817A5 (enExample) | ||
| JP2008546809A5 (enExample) | ||
| JP2016538288A5 (enExample) | ||
| HRP20211761T1 (hr) | Dvokomponentna kompozicija koja sadrži acetilsalicilnu kiselinu | |
| JP2021169526A5 (enExample) | ||
| JP2008520681A5 (enExample) | ||
| JP2015521598A5 (enExample) |